Please provide your email address to receive an email when new articles are posted on . RTx-015 optogenetic gene therapy is designed to restore vision by “reprogramming” retinal cells. The designation ...
RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...
Synopsis of Notification about the Statement of Financial Transactions (SFT) for Dividend income is as follows: With this notification, CBDT prescribes the guidelines for the preparation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results